Insilico Medicine and China Medical System Expand AI Collaboration in CNS Drug Discovery
Insilico Medicine and China Medical System Holdings have announced an expanded partnership to co-develop AI-powered treatments for central nervous system diseases, with potential milestone payments of up to 1.2 billion RMB.